Michael Allen
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Psychomotor Agitation | 25 | 2017 | 66 | 4.300 |
Why?
| Antipsychotic Agents | 23 | 2017 | 183 | 3.880 |
Why?
| Suicidal Ideation | 14 | 2023 | 399 | 2.640 |
Why?
| Suicide, Attempted | 22 | 2023 | 316 | 2.590 |
Why?
| Bipolar Disorder | 24 | 2012 | 208 | 2.540 |
Why?
| Emergency Services, Psychiatric | 15 | 2019 | 33 | 2.480 |
Why?
| Psychotic Disorders | 11 | 2016 | 123 | 1.670 |
Why?
| Emergency Service, Hospital | 17 | 2021 | 1829 | 1.600 |
Why?
| Schizophrenia | 8 | 2017 | 418 | 1.520 |
Why?
| Suicide | 20 | 2023 | 501 | 1.270 |
Why?
| Mass Screening | 15 | 2023 | 1024 | 1.220 |
Why?
| Benzodiazepines | 9 | 2016 | 115 | 1.150 |
Why?
| Restraint, Physical | 6 | 2016 | 92 | 1.100 |
Why?
| Mental Disorders | 10 | 2017 | 902 | 0.950 |
Why?
| Aggression | 4 | 2016 | 185 | 0.890 |
Why?
| Haloperidol | 5 | 2016 | 35 | 0.850 |
Why?
| Risk Management | 3 | 2019 | 89 | 0.840 |
Why?
| Antimanic Agents | 5 | 2009 | 15 | 0.830 |
Why?
| Psychological Tests | 2 | 2017 | 123 | 0.760 |
Why?
| Promethazine | 3 | 2016 | 4 | 0.730 |
Why?
| Emergency Medical Services | 6 | 2016 | 590 | 0.720 |
Why?
| Telephone | 2 | 2019 | 153 | 0.670 |
Why?
| Professional-Patient Relations | 1 | 2019 | 143 | 0.620 |
Why?
| Psychiatric Status Rating Scales | 14 | 2016 | 485 | 0.610 |
Why?
| Loxapine | 3 | 2012 | 4 | 0.600 |
Why?
| Lurasidone Hydrochloride | 1 | 2017 | 1 | 0.590 |
Why?
| Program Development | 1 | 2019 | 350 | 0.580 |
Why?
| Medical History Taking | 2 | 2017 | 114 | 0.580 |
Why?
| Risk Assessment | 11 | 2019 | 2987 | 0.560 |
Why?
| Physical Examination | 2 | 2017 | 222 | 0.540 |
Why?
| Injections, Intramuscular | 7 | 2008 | 118 | 0.530 |
Why?
| Emergency Medicine | 2 | 2017 | 227 | 0.510 |
Why?
| Adult | 43 | 2021 | 30718 | 0.490 |
Why?
| Anticonvulsants | 2 | 2009 | 181 | 0.480 |
Why?
| Humans | 82 | 2023 | 115587 | 0.470 |
Why?
| Communication | 1 | 2019 | 750 | 0.460 |
Why?
| Depressive Disorder, Major | 3 | 2008 | 304 | 0.460 |
Why?
| Evidence-Based Medicine | 2 | 2009 | 684 | 0.440 |
Why?
| Depression | 4 | 2023 | 1145 | 0.430 |
Why?
| Self-Injurious Behavior | 4 | 2021 | 114 | 0.430 |
Why?
| Lithium Carbonate | 2 | 2009 | 6 | 0.430 |
Why?
| Dibenzothiazepines | 2 | 2009 | 17 | 0.420 |
Why?
| Substance-Related Disorders | 6 | 2008 | 950 | 0.410 |
Why?
| Middle Aged | 29 | 2021 | 26999 | 0.410 |
Why?
| Acute Disease | 9 | 2017 | 914 | 0.400 |
Why?
| Valproic Acid | 3 | 2006 | 43 | 0.380 |
Why?
| Observation | 3 | 2009 | 50 | 0.370 |
Why?
| Male | 41 | 2021 | 55949 | 0.360 |
Why?
| Tranquilizing Agents | 2 | 2008 | 2 | 0.340 |
Why?
| Violence | 3 | 2011 | 202 | 0.330 |
Why?
| Female | 41 | 2021 | 59913 | 0.330 |
Why?
| Prospective Studies | 13 | 2023 | 6264 | 0.310 |
Why?
| Nicotine | 1 | 2011 | 266 | 0.310 |
Why?
| Comorbidity | 8 | 2019 | 1473 | 0.300 |
Why?
| Smoking | 3 | 2011 | 1457 | 0.300 |
Why?
| Risk Factors | 13 | 2023 | 8697 | 0.300 |
Why?
| Double-Blind Method | 6 | 2017 | 1660 | 0.290 |
Why?
| Primary Health Care | 6 | 2023 | 1518 | 0.290 |
Why?
| Disease Management | 2 | 2016 | 563 | 0.290 |
Why?
| Borderline Personality Disorder | 1 | 2007 | 11 | 0.280 |
Why?
| Informed Consent | 1 | 2008 | 161 | 0.280 |
Why?
| International Cooperation | 1 | 2007 | 174 | 0.280 |
Why?
| Drug Therapy, Combination | 5 | 2016 | 962 | 0.280 |
Why?
| Psychometrics | 4 | 2015 | 615 | 0.280 |
Why?
| Academic Medical Centers | 2 | 2011 | 414 | 0.270 |
Why?
| Guidelines as Topic | 1 | 2007 | 248 | 0.260 |
Why?
| Alcoholism | 2 | 2015 | 713 | 0.250 |
Why?
| Advisory Committees | 3 | 2017 | 208 | 0.240 |
Why?
| Hypnotics and Sedatives | 1 | 2005 | 134 | 0.240 |
Why?
| Midazolam | 3 | 2016 | 43 | 0.240 |
Why?
| Piperazines | 4 | 2007 | 314 | 0.230 |
Why?
| Motivation | 2 | 2006 | 498 | 0.230 |
Why?
| United States | 16 | 2021 | 12295 | 0.230 |
Why?
| Young Adult | 9 | 2021 | 10470 | 0.230 |
Why?
| Adolescent | 15 | 2021 | 17889 | 0.220 |
Why?
| Quality of Health Care | 1 | 2007 | 576 | 0.210 |
Why?
| Activities of Daily Living | 1 | 2005 | 352 | 0.200 |
Why?
| Pilot Projects | 2 | 2019 | 1377 | 0.200 |
Why?
| Thiazoles | 3 | 2007 | 110 | 0.200 |
Why?
| Cost-Benefit Analysis | 3 | 2022 | 548 | 0.200 |
Why?
| Patient Satisfaction | 1 | 2005 | 585 | 0.190 |
Why?
| Randomized Controlled Trials as Topic | 4 | 2016 | 1216 | 0.180 |
Why?
| Aged | 11 | 2019 | 19251 | 0.180 |
Why?
| Preventive Psychiatry | 1 | 2019 | 7 | 0.170 |
Why?
| Schizophrenic Psychology | 2 | 2011 | 86 | 0.160 |
Why?
| Quetiapine Fumarate | 2 | 2009 | 22 | 0.160 |
Why?
| Cognition Disorders | 1 | 2003 | 475 | 0.160 |
Why?
| Lorazepam | 2 | 2016 | 23 | 0.160 |
Why?
| Health Services Research | 2 | 2013 | 377 | 0.160 |
Why?
| Quality of Life | 2 | 2008 | 2385 | 0.160 |
Why?
| Diagnostic and Statistical Manual of Mental Disorders | 3 | 2008 | 230 | 0.150 |
Why?
| Consensus | 2 | 2017 | 532 | 0.150 |
Why?
| Hospitalization | 4 | 2021 | 1765 | 0.150 |
Why?
| Utilization Review | 2 | 2008 | 34 | 0.150 |
Why?
| Treatment Outcome | 8 | 2012 | 9159 | 0.140 |
Why?
| Severity of Illness Index | 7 | 2008 | 2578 | 0.140 |
Why?
| Risperidone | 2 | 2007 | 26 | 0.140 |
Why?
| Drug Administration Schedule | 2 | 2011 | 724 | 0.140 |
Why?
| Surveys and Questionnaires | 6 | 2021 | 4665 | 0.140 |
Why?
| Combined Modality Therapy | 4 | 2017 | 1127 | 0.140 |
Why?
| Longitudinal Studies | 6 | 2011 | 2416 | 0.140 |
Why?
| Referral and Consultation | 2 | 2019 | 646 | 0.140 |
Why?
| Antidepressive Agents, Second-Generation | 2 | 2007 | 38 | 0.140 |
Why?
| Altitude Sickness | 1 | 2017 | 152 | 0.130 |
Why?
| Antidepressive Agents | 3 | 2008 | 195 | 0.130 |
Why?
| Quinolones | 2 | 2007 | 97 | 0.130 |
Why?
| Patient Admission | 2 | 2008 | 175 | 0.130 |
Why?
| Aftercare | 1 | 2017 | 187 | 0.130 |
Why?
| Patient Discharge | 1 | 2021 | 770 | 0.130 |
Why?
| Dose-Response Relationship, Drug | 3 | 2011 | 1870 | 0.130 |
Why?
| Administration, Inhalation | 3 | 2012 | 644 | 0.130 |
Why?
| Multicenter Studies as Topic | 3 | 2019 | 249 | 0.130 |
Why?
| Cognition | 1 | 2022 | 980 | 0.130 |
Why?
| Decision Support Techniques | 1 | 2018 | 353 | 0.120 |
Why?
| Aged, 80 and over | 5 | 2017 | 6417 | 0.120 |
Why?
| Reproducibility of Results | 3 | 2015 | 2800 | 0.120 |
Why?
| Altitude | 1 | 2017 | 409 | 0.110 |
Why?
| Drug Administration Routes | 1 | 2013 | 41 | 0.110 |
Why?
| Crisis Intervention | 2 | 2019 | 30 | 0.110 |
Why?
| Age of Onset | 5 | 2008 | 450 | 0.110 |
Why?
| Military Personnel | 1 | 2019 | 525 | 0.100 |
Why?
| Caregivers | 2 | 2009 | 713 | 0.100 |
Why?
| Patient Safety | 1 | 2015 | 276 | 0.100 |
Why?
| Safety | 3 | 2009 | 298 | 0.100 |
Why?
| Hospitals, General | 2 | 2009 | 19 | 0.100 |
Why?
| Genetic Predisposition to Disease | 2 | 2010 | 2125 | 0.100 |
Why?
| Chronic Disease | 1 | 2017 | 1598 | 0.090 |
Why?
| Psychiatric Department, Hospital | 1 | 2011 | 15 | 0.090 |
Why?
| Administration, Oral | 3 | 2008 | 734 | 0.090 |
Why?
| Transdermal Patch | 1 | 2011 | 15 | 0.090 |
Why?
| Aripiprazole | 2 | 2007 | 17 | 0.090 |
Why?
| Aerosols | 1 | 2011 | 150 | 0.090 |
Why?
| Emergencies | 2 | 2010 | 147 | 0.090 |
Why?
| National Institutes of Health (U.S.) | 1 | 2010 | 107 | 0.090 |
Why?
| Psychiatry | 2 | 2016 | 155 | 0.090 |
Why?
| Affect | 2 | 2009 | 244 | 0.090 |
Why?
| Family Health | 2 | 2009 | 195 | 0.090 |
Why?
| Circadian Rhythm Signaling Peptides and Proteins | 1 | 2009 | 2 | 0.090 |
Why?
| Mental Health | 2 | 2013 | 571 | 0.090 |
Why?
| Placebos | 2 | 2011 | 198 | 0.090 |
Why?
| Chromosomes, Human, Pair 6 | 1 | 2010 | 44 | 0.090 |
Why?
| Colorado | 1 | 2019 | 4113 | 0.090 |
Why?
| Health Personnel | 2 | 2007 | 581 | 0.090 |
Why?
| Interview, Psychological | 1 | 2009 | 91 | 0.080 |
Why?
| Linkage Disequilibrium | 1 | 2010 | 247 | 0.080 |
Why?
| Long-Term Care | 1 | 2009 | 76 | 0.080 |
Why?
| Diagnosis, Dual (Psychiatry) | 2 | 2006 | 35 | 0.080 |
Why?
| Internship and Residency | 2 | 2009 | 951 | 0.080 |
Why?
| Health Status | 2 | 2019 | 728 | 0.080 |
Why?
| Prevalence | 2 | 2013 | 2264 | 0.080 |
Why?
| Age Factors | 4 | 2019 | 2907 | 0.080 |
Why?
| Personality Assessment | 2 | 2006 | 79 | 0.080 |
Why?
| Recreation | 1 | 2008 | 23 | 0.080 |
Why?
| Hospitals, Psychiatric | 1 | 2008 | 18 | 0.080 |
Why?
| Demography | 2 | 2006 | 261 | 0.080 |
Why?
| Brazil | 1 | 2008 | 93 | 0.080 |
Why?
| Depressive Disorder | 3 | 2008 | 336 | 0.080 |
Why?
| Follow-Up Studies | 6 | 2017 | 4440 | 0.080 |
Why?
| Nervous System Diseases | 1 | 2010 | 253 | 0.070 |
Why?
| Paroxetine | 1 | 2007 | 7 | 0.070 |
Why?
| Treatment Refusal | 1 | 2008 | 85 | 0.070 |
Why?
| Bupropion | 1 | 2007 | 39 | 0.070 |
Why?
| Conscious Sedation | 1 | 2008 | 79 | 0.070 |
Why?
| Smoking Cessation | 1 | 2011 | 377 | 0.070 |
Why?
| Quality Assurance, Health Care | 1 | 2009 | 315 | 0.070 |
Why?
| Switzerland | 1 | 2006 | 18 | 0.070 |
Why?
| Diagnosis, Differential | 2 | 2008 | 1357 | 0.070 |
Why?
| Personal Satisfaction | 1 | 2008 | 185 | 0.070 |
Why?
| Europe | 1 | 2007 | 336 | 0.070 |
Why?
| Narcotics | 1 | 2007 | 45 | 0.070 |
Why?
| Alcohol-Related Disorders | 1 | 2007 | 110 | 0.070 |
Why?
| Bayes Theorem | 1 | 2008 | 334 | 0.070 |
Why?
| Fluphenazine | 1 | 2006 | 5 | 0.070 |
Why?
| Time Factors | 4 | 2011 | 6165 | 0.070 |
Why?
| Health Services Misuse | 1 | 2006 | 36 | 0.070 |
Why?
| Lithium | 1 | 2005 | 36 | 0.070 |
Why?
| Interrupted Time Series Analysis | 2 | 2015 | 45 | 0.060 |
Why?
| Recurrence | 2 | 2007 | 952 | 0.060 |
Why?
| Curriculum | 2 | 2012 | 852 | 0.060 |
Why?
| Polymorphism, Single Nucleotide | 2 | 2010 | 1918 | 0.060 |
Why?
| Cocaine-Related Disorders | 1 | 2006 | 107 | 0.060 |
Why?
| Biomedical Research | 1 | 2010 | 588 | 0.060 |
Why?
| Practice Guidelines as Topic | 2 | 2016 | 1405 | 0.060 |
Why?
| Personality Inventory | 1 | 2005 | 135 | 0.060 |
Why?
| Serotonin Plasma Membrane Transport Proteins | 1 | 2005 | 72 | 0.060 |
Why?
| Dangerous Behavior | 1 | 2004 | 20 | 0.060 |
Why?
| Statistics as Topic | 1 | 2005 | 299 | 0.060 |
Why?
| Incidence | 2 | 2011 | 2335 | 0.060 |
Why?
| Urban Health Services | 1 | 2004 | 61 | 0.060 |
Why?
| Marijuana Abuse | 1 | 2006 | 209 | 0.060 |
Why?
| Linear Models | 1 | 2006 | 776 | 0.060 |
Why?
| Sex Factors | 3 | 2019 | 1736 | 0.050 |
Why?
| Cross-Sectional Studies | 3 | 2008 | 4435 | 0.050 |
Why?
| Analysis of Variance | 1 | 2006 | 1227 | 0.050 |
Why?
| Serotonin | 1 | 2005 | 296 | 0.050 |
Why?
| Kaplan-Meier Estimate | 2 | 2017 | 815 | 0.050 |
Why?
| Anxiety Disorders | 1 | 2005 | 310 | 0.050 |
Why?
| Secondary Prevention | 2 | 2017 | 223 | 0.050 |
Why?
| Polymorphism, Genetic | 1 | 2005 | 621 | 0.050 |
Why?
| Length of Stay | 1 | 2006 | 958 | 0.050 |
Why?
| Geriatric Assessment | 1 | 2003 | 176 | 0.050 |
Why?
| Disclosure | 1 | 2019 | 102 | 0.040 |
Why?
| Health Status Indicators | 1 | 2019 | 155 | 0.040 |
Why?
| Inservice Training | 1 | 2019 | 107 | 0.040 |
Why?
| DNA | 1 | 2005 | 1356 | 0.040 |
Why?
| Postcards as Topic | 1 | 2017 | 1 | 0.040 |
Why?
| Rhode Island | 1 | 2017 | 23 | 0.040 |
Why?
| Hotlines | 1 | 2017 | 29 | 0.040 |
Why?
| Substance Abuse Detection | 2 | 2009 | 62 | 0.040 |
Why?
| Case Management | 1 | 2017 | 62 | 0.040 |
Why?
| Attitude of Health Personnel | 1 | 2004 | 990 | 0.030 |
Why?
| Algorithms | 2 | 2019 | 1490 | 0.030 |
Why?
| Child | 3 | 2021 | 18488 | 0.030 |
Why?
| Cohort Studies | 4 | 2008 | 4944 | 0.030 |
Why?
| Disease Progression | 1 | 2003 | 2418 | 0.030 |
Why?
| Psychotherapy | 1 | 2017 | 149 | 0.030 |
Why?
| Socioeconomic Factors | 1 | 2019 | 1086 | 0.030 |
Why?
| Meta-Analysis as Topic | 1 | 2016 | 161 | 0.030 |
Why?
| Research Design | 2 | 2013 | 946 | 0.030 |
Why?
| Outpatients | 1 | 2017 | 330 | 0.030 |
Why?
| Logistic Models | 2 | 2012 | 1856 | 0.030 |
Why?
| Educational Status | 1 | 2015 | 413 | 0.030 |
Why?
| Models, Statistical | 1 | 2017 | 606 | 0.030 |
Why?
| Feasibility Studies | 1 | 2015 | 741 | 0.030 |
Why?
| Animals | 1 | 2013 | 32102 | 0.030 |
Why?
| Societies | 1 | 2012 | 39 | 0.030 |
Why?
| Case-Control Studies | 2 | 2010 | 3022 | 0.020 |
Why?
| Professional Competence | 1 | 2012 | 86 | 0.020 |
Why?
| Mental Status Schedule | 1 | 2009 | 34 | 0.020 |
Why?
| Health Care Surveys | 1 | 2011 | 538 | 0.020 |
Why?
| Continuity of Patient Care | 1 | 2011 | 255 | 0.020 |
Why?
| International Classification of Diseases | 1 | 2009 | 118 | 0.020 |
Why?
| Checklist | 1 | 2009 | 84 | 0.020 |
Why?
| Chromosome Mapping | 1 | 2010 | 489 | 0.020 |
Why?
| Cyclothymic Disorder | 1 | 2008 | 3 | 0.020 |
Why?
| Chi-Square Distribution | 1 | 2009 | 499 | 0.020 |
Why?
| Databases, Genetic | 1 | 2009 | 208 | 0.020 |
Why?
| Gene Frequency | 1 | 2009 | 485 | 0.020 |
Why?
| Self Concept | 1 | 2009 | 218 | 0.020 |
Why?
| Drug Delivery Systems | 1 | 2011 | 301 | 0.020 |
Why?
| Retrospective Studies | 3 | 2009 | 12608 | 0.020 |
Why?
| Reference Values | 1 | 2009 | 744 | 0.020 |
Why?
| Documentation | 1 | 2009 | 169 | 0.020 |
Why?
| Dyskinesia, Drug-Induced | 1 | 2007 | 11 | 0.020 |
Why?
| Triage | 1 | 2009 | 192 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2009 | 390 | 0.020 |
Why?
| Quality Indicators, Health Care | 1 | 2009 | 287 | 0.020 |
Why?
| Circadian Rhythm | 1 | 2009 | 371 | 0.020 |
Why?
| Models, Psychological | 1 | 2008 | 299 | 0.020 |
Why?
| Brain Injuries | 1 | 2010 | 451 | 0.020 |
Why?
| Patient Care Planning | 1 | 2005 | 142 | 0.020 |
Why?
| Predictive Value of Tests | 1 | 2009 | 1805 | 0.020 |
Why?
| Genotype | 1 | 2009 | 1786 | 0.010 |
Why?
| Drug Interactions | 1 | 2004 | 347 | 0.010 |
Why?
| Genome-Wide Association Study | 1 | 2009 | 1217 | 0.010 |
Why?
| Forecasting | 1 | 2004 | 333 | 0.010 |
Why?
| Drug Overdose | 1 | 2007 | 296 | 0.010 |
Why?
| Phenotype | 1 | 2010 | 2829 | 0.010 |
Why?
| Alcohol Drinking | 1 | 2007 | 648 | 0.010 |
Why?
| Critical Care | 1 | 2005 | 477 | 0.010 |
Why?
| Research | 1 | 2004 | 396 | 0.010 |
Why?
| Pregnancy | 1 | 2010 | 5548 | 0.010 |
Why?
|
|
Allen's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|